Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine + cET for Relapsed/Non-responding OCD
NCT02656342Phase 4Completed
- Sponsor
- Haukeland University Hospital
- Start
- Nov 2015
- Primary completion
- Sep 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of d-cycloserine in obsessive compulsive disorder (OCD), sponsored by Haukeland University Hospital. Started Nov 2015; status: completed.
02
Drugs
d-cycloserine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT02656342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02656342.